Pelvic Inflammatory Disease in COVID-19 Era

Status Recruiting

Clinical Trial Summary

The goal of this retrospective cohort study is to to scrutinize the impact of coronavirus disease 2019 (COVID-19) on incidence, demography and patient characteristics in Pelvic Inflammatory Disease comparing with the equal time duration, before and after lockdown was initiated in the country. The main aim of this study was to compare the demographic and clinical parameters between two cohorts before the onset of lockdown and within the pandemic.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Pelvic Inflammatory Disease

Clinical Trial Details

NCT number	NCT05648747
Study type	Observational
Source	Università degli Studi di Ferrara
Contact
Status	Recruiting
Phase
Start date	January 1, 2023
Completion date	January 30, 2024

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04723069` - Efficacy and Safety of Fuke Qianjin Capsule in Patients With Pelvic Inflammatory Diseases	Phase 2
Recruiting	`NCT03391440` - A Trial to Assess the Efficacy and Safety of Morinidazole in Women With Pelvic Inflammatory Disease	Phase 4
Completed	`NCT01671280` - Drug Use Investigation Of Azithromycin IV For Community-Acquired Pneumonia Or Pelvic Inflammatory Disease (Regulatory Post Marketing Commitment Plan)	N/A
Completed	`NCT00115388` - Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease	N/A
Not yet recruiting	`NCT02972151` - Clinical Research of TCM on Pelvic Inflammatory Disease Sequelae	Phase 2
Completed	`NCT01160640` - The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID)	Phase 2
Completed	`NCT01236131` - The Role of Novel Organisms in Acute Endometritis	N/A
Active, not recruiting	`NCT03994055` - Effect of an Anti-inflammatory Diet on Patients With Cervical Cancer	N/A
Completed	`NCT00871494` - Study Of Azithromycin Intravenous Formulation Against Pelvic Inflammatory Disease (PID) In Japan	Phase 3
Completed	`NCT00783419` - Rate of Pelvic Inflammatory Disease at St. Michael's Hospital
Completed	`NCT01799356` - Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled Trials	Phase 4
Recruiting	`NCT05408624` - Pilot Study Evaluating Outpatient Management of Tubo-ovarian Abscesses
Completed	`NCT01241110` - To Compare Ofloxacin With Azitromycin for Pelvic Inflammatory Disease (PID) Treatment	Phase 4
Completed	`NCT00453349` - A Trial Comparing Moxifloxacin Versus Levofloxacin Plus Metronidazole In Uncomplicated Pelvic Inflammatory Disease	Phase 3
Recruiting	`NCT04234945` - Effect of Prophylactic Antibiotics for Hysterosalpingography on Post Procedure Morbidity	N/A
Recruiting	`NCT06360965` - Clinical Trial of Acupoint Application in Improving the Sequelae of Pelvic Inflammatory Disease and Chronic Pelvic Pain	N/A
Completed	`NCT01793584` - Surgical Success After Laparoscopic vs Abdominal Hysterectomy	N/A
Completed	`NCT01299259` - Improving Primary Care Follow-up for Patients With Pelvic Inflammatory Disease	N/A
Completed	`NCT03054402` - First in Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and to Explore Pharmacodynamics of BAY1834845	Phase 1
Active, not recruiting	`NCT03828994` - Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID II	N/A